You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-IGF-1R-GTX-134
GTX-134

Chemical Structure : GTX-134

CAS No.: 1356059-82-9

GTX-134 (GTx-134, GTx134)

Catalog No.: PC-49759Not For Human Use, Lab Use Only.

GTx-134 (GTx 134) is a selective small-molecule inhibitor of IGF-1R and insulin receptor (IR) with biochemical IC50 of 97 nM and 187 nM, respectively.

Packing Price Stock Quantity
100 mg Get quote
250 mg Get quote
500 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

GTx-134 (GTx 134) is a selective small-molecule inhibitor of IGF-1R and insulin receptor (IR) with biochemical IC50 of 97 nM and 187 nM, respectively.
GTx-134 is selective for IGF-1R and closely related RTKs in a broad survey of the kinome.
GTx-134 (1-5 uM) inhibited IGF-1 induced phosphorylation of IGF-1R and Akt in a dose-dependent manner in HMCL, MM1.S cells, equally inhibited signaling downstream of both IGF-1R and IR.
GTx-134 inhibited the growth of genetically diverse human myeloma cell lines (HMCLs) at low micromolar level (IC50<5 uM), MM1.S, UTMC2, and H929 were most sensitive to the cytotoxic effects of GTx-134 (IC50 < 1.5 uM).
GTx-134 showed in vitro synergies when combined with dexamethasone or lenalidomide.
GTx-134 enhanced the activity of PD173074, a FGFR3 inhibitor, against t(4;14) myeloma cells.
GTx-134 inhibited IGF-1R signaling and induces apoptosis of primary MM cells, GTx-134 (40 mg/kg/day, i.p.)effectively reduced tumor burden in a HMCL xenografts model.

Physicochemical Properties

M.Wt 648.78
Formula C33H40N6O6S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-(4-((3-(2,4-dimethylphenoxy)-2-hydroxypropyl)amino)-2-oxo-1,2-dihydropyridin-3-yl)-6-(1-(2-(methylsulfonyl)ethyl)piperidin-4-yl)-6,7-dihydroimidazo[4,5-f]isoindol-5(3H)-one

References

1. Sheng-Ben Liang, et al. Clin Cancer Res. 2011 Jul 15;17(14):4693-704.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: